Here's one big reason I'm sticking with my Apple Watch Series 7 and forgoing the Series 10
Briefly

from ZDNET1 month ago
The removal of blood oxygen tracking from the Apple Watch Series 10 in the US highlights ongoing legal battles impacting consumer features, particularly due to a patent dispute with Masimo.
ZDNEThttps://www.zdnet.com/article/heres-one-big-reason-im-sticking-with-my-apple-watch-series-7-and-forgoing-the-series-10/
The ITC's ruling in October 2023 forced Apple to disable the blood oxygen monitoring feature in new smartwatch models to continue selling Series 9 and Ultra 2 without infringing patent rights.
ZDNEThttps://www.zdnet.com/article/heres-one-big-reason-im-sticking-with-my-apple-watch-series-7-and-forgoing-the-series-10/
Apple Watch's blood oxygen feature, available in older models, utilizes light sensors to measure oxygen saturation by analyzing how red and infrared light is absorbed by the blood.
ZDNEThttps://www.zdnet.com/article/heres-one-big-reason-im-sticking-with-my-apple-watch-series-7-and-forgoing-the-series-10/
Masimo's patent claims against Apple underline a critical intersection between technology development and intellectual property rights, posing significant challenges for product features in the competitive smartwatch market.
ZDNEThttps://www.zdnet.com/article/heres-one-big-reason-im-sticking-with-my-apple-watch-series-7-and-forgoing-the-series-10/
Read at ZDNET
#apple-watch #health-technology #patent-dispute #masimo #wearable-devices
[
]
[
|
]